Tamoxifen Prediction Study in Patients With ER+ Breast Cancer
Condition: ER+ Breast Cancer Intervention: Drug: Tamoxifen Sponsor: Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2022 Category: Research Source Type: clinical trials